|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0018787,
umls-concept:C0021102,
umls-concept:C0021107,
umls-concept:C0030705,
umls-concept:C0037633,
umls-concept:C0087111,
umls-concept:C0180307,
umls-concept:C0205554,
umls-concept:C0279776,
umls-concept:C0814225,
umls-concept:C1099034,
umls-concept:C1382100,
umls-concept:C1961129
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2004-10-6
|
|
pubmed:abstractText |
In 2003, the Centers for Medicaid and Medicare Services recommended QRS duration as a means to identify MADIT II-like patients suitable for implanted cardiac defibrillator (ICD) therapy. We compared the ability of microvolt T-wave alternans and QRS duration to identify groups at high and low risk of dying among heart failure patients who met MADIT II criteria for ICD prophylaxis.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:BiggerJ ThomasJTJr,
pubmed-author:BloomfieldDaniel MDM,
pubmed-author:CurtisAnneA,
pubmed-author:DavidenkoJorgeJ,
pubmed-author:FontaineJohnJ,
pubmed-author:HolmesDouglasD,
pubmed-author:KaufmanElizabeth SES,
pubmed-author:NamerowPearila BPB,
pubmed-author:ParidesMichaelM,
pubmed-author:RussoAndreaA,
pubmed-author:ShinnTimothyT,
pubmed-author:SteinmanRichard CRC,
pubmed-author:TangChuenC
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
5
|
|
pubmed:volume |
110
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1885-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15451804-Aged,
pubmed-meshheading:15451804-Arrhythmias, Cardiac,
pubmed-meshheading:15451804-Cardiovascular Agents,
pubmed-meshheading:15451804-Case Management,
pubmed-meshheading:15451804-Combined Modality Therapy,
pubmed-meshheading:15451804-Death, Sudden, Cardiac,
pubmed-meshheading:15451804-Defibrillators, Implantable,
pubmed-meshheading:15451804-Electric Countershock,
pubmed-meshheading:15451804-Electrocardiography,
pubmed-meshheading:15451804-False Negative Reactions,
pubmed-meshheading:15451804-Female,
pubmed-meshheading:15451804-Heart Failure,
pubmed-meshheading:15451804-Humans,
pubmed-meshheading:15451804-Life Tables,
pubmed-meshheading:15451804-Male,
pubmed-meshheading:15451804-Middle Aged,
pubmed-meshheading:15451804-Myocardial Infarction,
pubmed-meshheading:15451804-Prognosis,
pubmed-meshheading:15451804-Prospective Studies,
pubmed-meshheading:15451804-Risk,
pubmed-meshheading:15451804-Survival Analysis,
pubmed-meshheading:15451804-Treatment Outcome,
pubmed-meshheading:15451804-United States,
pubmed-meshheading:15451804-Ventricular Dysfunction, Left
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
|
|
pubmed:affiliation |
Data Coordinating Center, The MTWA in CHF Study, PH 9-103D, Department of Medicine, Columbia University, 630 W 168th St, New York, NY 10032, USA. dmb9@columbia.edu.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
